Merit Medical Systems — Third Quarter 2026 Earnings Summary

Merit Medical Systems reported third-quarter 2026 revenue of $416.2 million, representing an 8.4% increase from the prior year period. The company achieved a GAAP operating margin of 14.1% and a non-GAAP operating margin of 21.3%, while non-GAAP earnings per share rose 22% to $1.12. Driven by strong performance in both Foundational and Therapeutic product platforms, Merit raised its full-year 2026 revenue guidance to a range of $1.635 billion to $1.642 billion and increased its non-GAAP EPS guidance to $4.33–$4.37. Year-to-date cash flow from operations totaled $175.2 million, with free cash flow generation reaching $129.5 million.